Table 3.

Standardised scores of each domain by AGREE II of guidelines

	Scope and purpose (%)	Stakeholder involvement (%)	Rigour of development (%)	Clarity of presentation (%)	Applicability (%)	Editorial independence (%)	Average scores (%)
AAP	69.44	26.39	36.98	87.50	25.00	95.83	56.86
EAU/ESPU	75.00	31.94	45.83	73.61	33.33	97.92	59.61
SINePe	88.89	55.56	48.96	84.72	61.46	95.83	72.57
KHA-CARI	54.17	25.00	34.90	84.72	34.38	0.00	38.86
CPS	73.61	26.39	39.58	70.83	35.42	0.00	40.97
ISPN	62.50	40.28	25.52	63.89	39.58	0.00	38.63
NICE	91.67	41.67	26.56	72.22	53.13	0.00	47.54
Pyelonephritis guideline	66.67	12.50	25.00	75.00	29.17	0.00	34.72
CMA-CSP	75.00	59.72	54.17	68.06	22.92	97.92	62.96
Means±SD (%)	72.99±11.19	35.49±14.41	37.50±10.05	75.62±7.75	37.15±11.98	43.06±48.14	/